Zacks Research Has Positive Outlook for McKesson Q2 Earnings

McKesson Co. (NYSE:MCK) – Stock analysts at Zacks Research upped their Q2 2027 earnings estimates for shares of McKesson in a research note issued to investors on Tuesday, May 6th. Zacks Research analyst R. Department now expects that the company will post earnings per share of $9.06 for the quarter, up from their prior estimate of $9.04. The consensus estimate for McKesson’s current full-year earnings is $32.77 per share. Zacks Research also issued estimates for McKesson’s FY2027 earnings at $41.14 EPS.

A number of other equities research analysts have also issued reports on the company. Mizuho upped their price target on McKesson from $630.00 to $690.00 and gave the company a “neutral” rating in a research report on Thursday, April 3rd. Cfra Research lowered McKesson from a “moderate buy” rating to a “hold” rating in a report on Friday, April 4th. Morgan Stanley raised their price objective on shares of McKesson from $642.00 to $745.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 2nd. Citigroup dropped their price target on shares of McKesson from $713.00 to $677.00 and set a “buy” rating for the company in a research note on Friday, January 10th. Finally, Wells Fargo & Company increased their price objective on McKesson from $641.00 to $691.00 and gave the stock an “equal weight” rating in a research report on Friday, March 14th. Three investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $681.00.

McKesson Stock Up 1.5 %

Shares of MCK stock opened at $721.98 on Wednesday. McKesson has a 52-week low of $464.42 and a 52-week high of $728.48. The stock has a market cap of $90.48 billion, a PE ratio of 33.06, a price-to-earnings-growth ratio of 1.29 and a beta of 0.53. The business has a 50-day simple moving average of $676.31 and a 200-day simple moving average of $617.52.

McKesson (NYSE:MCK) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $8.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of MCK. CWA Asset Management Group LLC lifted its holdings in shares of McKesson by 9.5% during the fourth quarter. CWA Asset Management Group LLC now owns 921 shares of the company’s stock worth $525,000 after purchasing an additional 80 shares during the period. Bank of New Hampshire raised its stake in shares of McKesson by 24.2% during the 4th quarter. Bank of New Hampshire now owns 154 shares of the company’s stock worth $88,000 after buying an additional 30 shares in the last quarter. Range Financial Group LLC acquired a new stake in shares of McKesson in the 4th quarter valued at approximately $423,000. Fulton Bank N.A. boosted its stake in shares of McKesson by 6.2% in the fourth quarter. Fulton Bank N.A. now owns 7,450 shares of the company’s stock valued at $4,246,000 after buying an additional 434 shares in the last quarter. Finally, Legacy Private Trust Co. grew its holdings in McKesson by 1.0% during the fourth quarter. Legacy Private Trust Co. now owns 15,518 shares of the company’s stock worth $8,844,000 after acquiring an additional 150 shares during the period. 85.07% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, CEO Brian S. Tyler sold 8,961 shares of the company’s stock in a transaction dated Friday, February 21st. The stock was sold at an average price of $597.99, for a total transaction of $5,358,588.39. Following the completion of the transaction, the chief executive officer now directly owns 60,664 shares of the company’s stock, valued at approximately $36,276,465.36. This represents a 12.87 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Leann B. Smith sold 188 shares of the firm’s stock in a transaction dated Wednesday, February 12th. The stock was sold at an average price of $609.59, for a total value of $114,602.92. Following the sale, the executive vice president now directly owns 1,051 shares in the company, valued at $640,679.09. This trade represents a 15.17 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 18,110 shares of company stock worth $10,855,706 in the last 90 days. Corporate insiders own 0.11% of the company’s stock.

McKesson Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, July 1st. Investors of record on Monday, June 2nd will be paid a $0.71 dividend. The ex-dividend date is Monday, June 2nd. This represents a $2.84 dividend on an annualized basis and a yield of 0.39%. McKesson’s dividend payout ratio is currently 13.00%.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.